EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Suppression of SLC39A6‐CREB1 axis in liver cancer causes PCK1 ‐mediated mitochondrial dysfunction

Ze Yu iD, Cheng Chen, Hongpeng Gu, Jinliang Dong, Yingjie Zhang, Jie Wang, Haijie Ma, Guoqiang Zhang

Cell Proliferation · 2023

DOI: 10.1111/cpr.13527 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Cell Proliferation, 2023. Verfasst von Ze Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Cation Transport Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma is one of the most common cancers worldwide and represents a major global health-care challenge.1 Infection with

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCation Transport ProteinsHumansMitochondriaNeoplasm ProteinsCyclic AMP Response Element-Binding ProteinPhosphoenolpyruvate Carboxykinase (GTP)Intracellular Signaling Peptides and Proteins

Substanzen

SLC39A6 protein, humanNeoplasm ProteinsCation Transport ProteinsCREB1 protein, humanCyclic AMP Response Element-Binding ProteinPCK1 protein, humanPhosphoenolpyruvate Carboxykinase (GTP)Intracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of General Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang, China.
  • The Laboratory of Cytobiology and Molecular Biology, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang, China.
  • The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Department of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
  • Department of General Surgery, Zhoushan Hospital, Zhejiang University School of Medicine, Zhoushan, Zhejiang, China.

ORCID-Profile: Ze Yu

Förderung

  • China Postdoctoral Science Foundation

Zitieren

APA

Yu, Z., Chen, C., Gu, H., Dong, J., Zhang, Y., Wang, J., Ma, H., & Zhang, G. (2023). Suppression of SLC39A6‐CREB1 axis in liver cancer causes PCK1 ‐mediated mitochondrial dysfunction. Cell Proliferation. https://doi.org/10.1111/cpr.13527

Vancouver

Yu Z, Chen C, Gu H, Dong J, Zhang Y, Wang J, et al. Suppression of SLC39A6‐CREB1 axis in liver cancer causes PCK1 ‐mediated mitochondrial dysfunction. Cell Proliferation. 2023. doi:10.1111/cpr.13527

BibTeX
@article{Yu2023,
  author = {Yu, Ze and Chen, Cheng and Gu, Hongpeng and Dong, Jinliang and Zhang, Yingjie and Wang, Jie and Ma, Haijie and Zhang, Guoqiang},
  title = {Suppression of SLC39A6‐CREB1 axis in liver cancer causes PCK1 ‐mediated mitochondrial dysfunction},
  journal = {Cell Proliferation},
  year = {2023},
  doi = {10.1111/cpr.13527}
}
Kostenlos starten →